A review of Dynamin 2 involvement in cancers highlights a promising therapeutic target

by Delphine Trochet, Marc Bitoun
Published 2021-07-01

Reprogramming the Dynamin 2 mRNA by Spliceosome-mediated RNA Trans-splicing

by Delphine Trochet, Bernard Prudhon, Arnaud Jollet, Stéphanie Lorain, Marc Bitoun
Published 2016-01-01

Allele‐specific silencing therapy for Dynamin 2‐related dominant centronuclear myopathy

by Delphine Trochet, Bernard Prudhon, Maud Beuvin, Cécile Peccate, Stéphanie Lorain, Laura Julien, Sofia Benkhelifa‐Ziyyat, Aymen Rabai, Kamel Mamchaoui, Arnaud Ferry, Jocelyn Laporte, Pascale Guicheney, Stéphane Vassilopoulos, Marc Bitoun
Published 2018-02-01